Developing agent applied to tumor radiology department
A technology of tumor radiation and contrast agent, which is applied in the field of contrast agent in the Department of Oncology Radiology, which can solve the problems of large background noise, short effective observation time of resonance imaging, and poor image contrast quality, so as to reduce background noise and improve image contrast quality , the effect of small particle size
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] The present invention proposes a contrast agent for use in oncology radiology. Its raw materials include, in parts by weight, 2 parts of citric acid buffer solution of the contrast agent Omniscan, 50 parts of chloroform, 1 part of dimethyl sulfoxide, and 100 parts of soybean lecithin, 2 parts of dilauroyl lecithin, 3 parts of dipalmitoyl lecithin, 1 part of cholesterol, 12 parts of PEG3000, 1 part of palmitic acid PEG3000 monoester, 1 part of palmitic acid-GG peptide.
Embodiment 2
[0017] The present invention proposes a contrast agent for use in oncology radiology. Its raw materials include by weight: 12 parts of citric acid buffer solution of the contrast agent Omniscan, 20 parts of chloroform, 2 parts of dimethyl sulfoxide, 30 parts of soybean lecithin, 10 parts of dilauroyl lecithin, 1 part of dipalmitoyl lecithin, 10 parts of cholesterol, 2 parts of PEG3000, 4 parts of palmitic acid PEG3000 monoester, and 0.5 part of palmitic acid-GG peptide.
Embodiment 3
[0019] The present invention proposes a contrast agent applied to the oncology radiology department, and its raw materials include by weight: 4 parts of citric acid buffer solution of the contrast agent Omniscan, 40 parts of chloroform, 1.2 parts of dimethyl sulfoxide, 80 parts of soybean lecithin, 4 parts of dilauroyl lecithin, 2.5 parts of dipalmitoyl lecithin, 2 parts of cholesterol, 10 parts of PEG3000, 2 parts of palmitic acid PEG3000 monoester, and 0.8 part of palmitic acid-GG peptide.
[0020] In the citric acid buffer solution of the developer Omniscan, the pH of the developer Omniscan is 5.2, and the concentration of the gadolinium chelate is 18 mg / mL.
PUM
Property | Measurement | Unit |
---|---|---|
Concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com